This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: J Urgen Distler: Innovator in Secondary-Metabolite Biosynthesis
Introduction
J Urgen Distler is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of secondary-metabolite biosynthesis. His work has implications for various applications, including pharmaceuticals and agriculture.
Latest Patents
J Urgen Distler holds a patent for "Secondary-metabolite biosynthesis genes from actinomycetes, method of." This patent represents his innovative approach to harnessing the genetic potential of actinomycetes for the production of valuable secondary metabolites. He has 1 patent to his name, showcasing his expertise in this specialized field.
Career Highlights
Distler is currently employed at Hoechst Aktiengesellschaft, a prominent company in the chemical and pharmaceutical industry. His role at Hoechst has allowed him to collaborate with leading experts and contribute to groundbreaking research in biotechnology.
Collaborations
Throughout his career, J Urgen Distler has worked alongside talented colleagues, including Susanne Grabley and Michael Stockmann. These collaborations have enriched his research and expanded the impact of his innovations.
Conclusion
J Urgen Distler's contributions to secondary-metabolite biosynthesis highlight his role as an influential inventor in the biotechnology sector. His patent and collaborations reflect his commitment to advancing scientific knowledge and practical applications in this important field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile